ENDV - Endonovo Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.038
+0.001 (+2.70%)
At close: 3:15PM EST
Stock chart is not supported by your current browser
Previous Close0.037
Open0.042
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.036 - 0.042
52 Week Range0.015 - 0.078
Volume1,010,045
Avg. Volume3,349,053
Market Cap14.143M
Beta (3Y Monthly)-1.67
PE Ratio (TTM)N/A
EPS (TTM)-0.026
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire5 days ago

    Endonovo Therapeutics Announces Complimentary New Product

    LOS ANGELES, CA, Nov. 08, 2018 -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™.

  • GlobeNewswire23 days ago

    Endonovo Therapeutics Provides Update on Liver Study

    LOS ANGELES, CA, Oct. 22, 2018 -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™.

  • We're sorry this is all we were able to find about this topic.